基于MRI的影像组学列线图术前鉴别肝内肿块型胆管癌与可切除结直肠癌肝转移
该研究基于多参数MRI建立影像组学列线图,用于术前鉴别肝内肿块型胆管癌(IMCC)与结直肠癌肝转移(CRLM)。共纳入训练组133例、内部验证组57例、外部验证组51例。列线图结合影像组学特征与临床因素(血清CEA水平和肿瘤直径),在训练组和外部验证组的AUC分别为0.94和0.92,显示良好的鉴别能力和校准度。
要点
- 影像组学列线图在外部验证组AUC达0.92,有助于术前无创鉴别IMCC与CRLM。
- 列线图整合了影像组学特征、血清CEA水平和肿瘤直径。
- 影像组学模型鉴别能力优于临床模型(外部验证组AUC 0.90 vs 0.81)。
核心结论
- 基于多参数MRI的影像组学列线图结合影像组学特征与临床因素(血清CEA水平和肿瘤直径),可作为术前无创鉴别IMCC与CRLM的可靠工具。
研究设计与样本
- 回顾性研究,训练组133例(IMCC 64例,CRLM 69例),内部验证组57例(IMCC 29例,CRLM 28例),外部验证组51例(IMCC 23例,CRLM 28例)。
- 基于多参数MRI提取影像组学特征,采用LASSO算法筛选特征建立影像组学模型。
- 临床变量和MRI征象经单因素和多因素分析筛选建立临床模型,列线图结合影像组学模型与临床模型。
诊断标准与关键数值
- 影像组学模型在训练组AUC为0.92(95%CI 0.87-0.96),外部验证组AUC为0.90(95%CI 0.82-0.98)。
- 临床模型在训练组AUC为0.74(95%CI 0.66-0.83),外部验证组AUC为0.81(95%CI 0.69-0.93)。
- 影像组学列线图在训练组AUC为0.94(95%CI 0.90-0.97),外部验证组AUC为0.92(95%CI 0.84-1.00)。
- 共筛选出6个影像组学特征用于构建影像组学模型。
临床应用与阅片要点
- 术前可结合多参数MRI影像组学列线图辅助鉴别IMCC与CRLM,为治疗策略和预后预测提供参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To establish a radiomics nomogram based on multiparameter magnetic resonance (MR) images for preoperatively differentiating intrahepatic mass-forming cholangiocarcinoma (IMCC) from colorectal cancer liver metastasis (CRLM).
MATERIALS AND METHODS: A total of 133 patients in training cohort (64 IMCC and 69 CRLM), 57 patients in internal validation cohort (29 IMCC and 28 CRLM), and 51 patients (23 IMCC and 28 CRLM) in external validation cohort were included. Radiomics features were extracted from the multiparameter MR images and selected by the least absolute shrinkage and selection operator algorithm to establish the radiomics model. Clinical variables and magnetic resonance imaging (MRI) findings were selected by univariate and multivariate analyses to construct a clinical model. The radiomics nomogram was combined with radiomics model and clinical model.
RESULTS: Six features were selected to construct the radiomics model. The radiomics signature showed better discrimination than the clinical model in the training cohort (Area Under the Curve (AUC), 0.92; 95% confidence interval (CI), 0.87-0.96 vs. AUC, 0.74; 95% CI, 0.66-0.83) and the external validation cohort (AUC, 0.90; 95% CI, 0.82-0.98 vs. AUC, 0.81; 95% CI, 0.69-0.93). The radiomics nomogram showed the best discrimination performance with favorable calibration in the training cohort (AUC, 0.94; 95% CI, 0.90-0.97) and the external validation cohort (AUC, 0.92; 95% CI, 0.84-1.00).
CONCLUSION: The radiomics nomogram combining radiomics signatures based on multiparameter MRI with clinical factors (serum carcinoembryonic antigen level and tumor diameter) may provide a reliable and noninvasive tool to discriminate IMCC from CRLM, which could help guide treatment strategies and prognosis preoperatively prediction.
引用
- Xu, Ye, Li, et al. MRI-Based Radiomics Nomogram for Preoperatively Differentiating Intrahepatic Mass-Forming Cholangiocarcinoma From Resectable Colorectal Liver Metastases. Acad Radiol. 2023. PMID: 37414635. doi:10.1016/j.acra.2023.04.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。